IOSP vs. BCPC, ASH, CC, HUN, NGVT, HWKN, PRM, LOOP, GURE, and OLN
Should you be buying Innospec stock or one of its competitors? The main competitors of Innospec include Balchem (BCPC), Ashland (ASH), Chemours (CC), Huntsman (HUN), Ingevity (NGVT), Hawkins (HWKN), Perimeter Solutions (PRM), Loop Industries (LOOP), Gulf Resources (GURE), and Olin (OLN). These companies are all part of the "chemicals & allied products" industry.
Balchem (NASDAQ:BCPC) and Innospec (NASDAQ:IOSP) are both mid-cap basic materials companies, but which is the better investment? We will compare the two companies based on the strength of their valuation, profitability, institutional ownership, risk, earnings, community ranking, dividends, media sentiment and analyst recommendations.
Balchem pays an annual dividend of $0.39 per share and has a dividend yield of 0.2%. Innospec pays an annual dividend of $1.44 per share and has a dividend yield of 1.1%. Balchem pays out 11.0% of its earnings in the form of a dividend. Innospec pays out 25.9% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Balchem has raised its dividend for 15 consecutive years and Innospec has raised its dividend for 3 consecutive years.
Balchem presently has a consensus target price of $170.00, indicating a potential upside of 8.67%. Given Innospec's higher possible upside, equities research analysts clearly believe Balchem is more favorable than Innospec.
Balchem has a net margin of 12.35% compared to Balchem's net margin of 7.14%. Balchem's return on equity of 13.69% beat Innospec's return on equity.
Balchem received 58 more outperform votes than Innospec when rated by MarketBeat users. Likewise, 66.72% of users gave Balchem an outperform vote while only 65.79% of users gave Innospec an outperform vote.
87.9% of Balchem shares are held by institutional investors. Comparatively, 96.6% of Innospec shares are held by institutional investors. 1.8% of Balchem shares are held by insiders. Comparatively, 1.4% of Innospec shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.
Innospec has higher revenue and earnings than Balchem. Innospec is trading at a lower price-to-earnings ratio than Balchem, indicating that it is currently the more affordable of the two stocks.
In the previous week, Balchem had 12 more articles in the media than Innospec. MarketBeat recorded 26 mentions for Balchem and 14 mentions for Innospec. Balchem's average media sentiment score of 0.92 beat Innospec's score of 0.73 indicating that Innospec is being referred to more favorably in the news media.
Balchem has a beta of 0.72, indicating that its share price is 28% less volatile than the S&P 500. Comparatively, Innospec has a beta of 1.11, indicating that its share price is 11% more volatile than the S&P 500.
Summary
Balchem beats Innospec on 11 of the 20 factors compared between the two stocks.
Get Innospec News Delivered to You Automatically
Sign up to receive the latest news and ratings for IOSP and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding IOSP and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Innospec Competitors List
Related Companies and Tools
